We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
163 hedge funds and large institutions have $529M invested in Anika Therapeutics in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 58 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
2% more funds holding
Funds holding: 160 → 163 (+3)
5% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 58
14% less capital invested
Capital invested by funds: $617M → $529M (-$88.1M)
41% less call options, than puts
Call options by funds: $1.06M | Put options by funds: $1.8M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
163
Holders Change
+3
Holders Change %
+1.88%
% of All Funds
4.35%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
18
Increased
61
Reduced
58
Closed
15
Calls
$1.06M
Puts
$1.8M
Net Calls
-$731K
Net Calls Change
+$22K
Top Buyers
| 1 |
Millennium Management
New York
|
+$7.32M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.61M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$3.94M |
| 4 |
Goldman Sachs
New York
|
+$2.85M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.16M |
